logo
  

INOVIO Issues Updates For VGX-3100; Long-term Data Favorable From REVEAL1

INOVIO (INO) issued updates on the phase 3 program for VGX-3100 for HPV-associated cervical high-grade squamous intraepithelial lesions. The second global phase 3 clinical trial of VGX-3100 for cervical HSIL is fully enrolled and top-line efficacy and safety data are expected to be available in the second half of 2022. The company completed the 52-week safety follow-up of participants in REVEAL1, global phase 3 trial of VGX-3100, and the safety profile of VGX-3100 observed at week 36 remained well-tolerated through week 88. Participants treated with VGX-3100 who met the primary endpoint at Week 36 remained clear of HPV-16 and/or HPV-18 at week 88.

Also, INOVIO is advancing its partnership with QIAGEN to co-develop a liquid biopsy-based diagnostic product based on next-generation sequencing technology to guide clinical decision-making for the use of VGX-3100 in cervical HSIL.

Separately, INOVIO's partner ApolloBio dosed the first participant in the phase 3 trial of VGX-3100 in China. The phase 3 trial is expected to enroll 84 participants.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS has issued a public health alert for Plumrose USA's ready-to-eat or RTE ham product citing that it may not be fully cooked due to underprocessing. The product subject to the public health alert is 1-lb resealable plastic packages containing "Great Value Black Forest Ham Water Added" with a "BEST IF USED BY 07/15/22". America New York Ri Wang Food Group Co., Ltd. is recalling around 14,635 pounds of ready-to-eat or RTE pork sausage products due to possible contamination with extraneous materials, specifically metal, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS said. The TJX Companies, Inc. (TJX) said its first-quarter pretax profit margin and earnings per share, each on an adjusted basis, exceeded its plans even though sales were slightly below planned range. Adjusted pretax margin was 9.4%, excluding a 1.9 percentage point charge related to a write-down of the...
Follow RTT